Barton recently announced a $3 million equity accretive placement priced at a ~4% premium to its last traded price, and a ~25% premium to its 20 trading day volume weighted average price (VWAP). [2] ...
Baseline Therapeutics, Inc. ("Baseline"), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of ...
Reprinted with permission from the Association of Clinical Documentation Improvement Specialists (ACDIS) CDI Journal.While many clinical documentation improvement programs try to measure the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results